NPLATE romiplostim (rbe) 625 microgram powder for injection vial

Amgen Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 51403e84610691a3
Product Name: NPLATE romiplostim (rbe) 625 microgram powder for injection vial
Artg Id: 147188
Artg Name: NPLATE romiplostim (rbe) 625 microgram powder for injection vial
Sponsor: Amgen Australia Pty Ltd
Company Detail Path: /organization/amgen-australia-pty-ltd
Artg Date: 2008-08-08
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/08bce97f282e08f6d5b61bbd5da6fb41.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/2393e2ab04828cf2f1e4319b559ca0f4.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

51403e84610691a3

Type

Standard